Rate My Professor Boyd Strauss

Boyd Strauss, MBBS (Monash), PhD (Deakin), FRACP, FRCPath, FRCPE, serves as Adjunct Professor of Medicine in the School of Clinical Sciences at Monash University. He graduated from Monash University Medical School in 1973 and earned his PhD from Deakin University in 1988. Recognized as the first internal medicine physician in Australia trained specifically in clinical nutrition, incorporating gastroenterology and endocrinology, he obtained his FRACP diploma in 1985.

Throughout his distinguished career, Strauss held key positions including Research Fellow in the Department of Clinical Nutrition at the University of Gothenburg, Sweden (1984-1985); Lecturer in Human Nutrition at Deakin University (1986-1989); Lecturer in Medicine (1989-1991) and Senior Lecturer in Community Medicine (1993) at Monash University; and Associate Professor of Medicine at Monash University from 2001. At Monash Medical Centre, he has been Physician-in-Charge of the Body Composition Laboratory since 1989, Director of Clinical Nutrition and Metabolism since 1998, and a physician in general internal medicine since 2002. From 2005 to 2009, he acted as Chairman of the Discipline of Nutrition and Dietetics within the Department of Medicine at Monash University, overseeing the undergraduate dietetics course and developing the postgraduate research program. Since 2011, he holds his principal Monash appointment as Adjunct Professor of Medicine, and he is currently Reader in Medicine at the University of Manchester.

His research specializes in the interface between body composition measurement and clinical medicine, with over 140 peer-reviewed publications. Notable recent works include "Abnormal Trabecular Bone Score, Lower Bone Mineral Density and Lean Mass in Young Women With Premature Ovarian Insufficiency Are Prevented by Oestrogen Replacement" (2022), "Evaluation of an alternative skeletal muscle index for skeletal muscle mass assessment in a group of Australian women" (2022), "Novel Lipidomic Signature Associated With Metabolic Risk in Women With and Without Polycystic Ovary Syndrome" (2022), "The making of a classic: The 1974 Durnin-Womersley body composition paper" (2022), and "A three-year longitudinal study comparing bone mass, density, and geometry measured by DXA, pQCT, and bone turnover markers in children with PKU taking L-amino acid or glycomacropeptide protein substitutes" (2021).